Global CFO and MD for Corporate development for INSUDPHARMA Group (which includes Chemo, Mabxience and Exeltis BU through more than 150 subs in 45 countries).European senior Executive, with 20 yrs experience, leading and managing multinational/ cross-functional teams in Corporate Finance and Business Development projects in very demanding environments (IPO's, mergers, restructuring, LBO's). I started my career in 94 in Advisory/Auditing in Arthur Andersen in Madrid Office. Then joint Telefonica Group (Ibex 35: TEF) to build from scratch its internet division TerraLycos (Nasdaq: TRLY) that was 4th worldwide internet player present in 40 countries with more than 100 subsidiaries in 6 years (IPO, 12Bn Lycos merger, Telefonica Spin off, etc.). Later I moved to the European leading Public Real Estate Company Fadesa (Ibex35: FAD) as CFO to merge and IPO and restructure a 5Bn acquisition debt. Previously joining Chemo Group, I worked with The Carlyle Group in its main Spanish LBO.I hold a BS degree in Business Administration (double major in Corporate Finance and Auditing), MBA from IE (Instituto de Empresa) and Alumni from Wharton School of Business (University Of Pennsylvania) (Advanced Management Program). Also hold different leadership programs in INSEAD and HBS.MBA class teacher in Valuation and Financing in Spanish MBA program for Pharma Companies.